BPC-157
Body Protection Compound 157 · Pentadecapeptide BPC 157
A 15-amino-acid peptide derived from a gastric protein, studied in animal models for soft-tissue and gut healing.
At a glance
- Category
- Healing & Recovery
- Half-life
- Not well characterised
- Typical vial sizes
- 5 mg · 10 mg
- Commonly cited dose
- 200–500 mcg
- Frequency
- once or twice daily
- Routes
- Subcutaneous · Oral
A 5 mg vial, worked through.
Reconstituting a 5 mg vial of BPC-157 with 2 mL of bacteriostatic water gives 2.5 mg/mL. A 200 mcg dose is then:
Storage
- Lyophilised (unmixed)
- Refrigerated; stable at room temperature for short periods.
- Reconstituted
- Refrigerate at 2–8°C. Commonly cited as usable for ~30 days.
What people log it against
Outcomes users commonly track alongside this compound. Listing them is not a claim that it produces them.
- Tendon and ligament recovery
- Gut discomfort
- Post-injury tracking
References
Each source below establishes only the specific claim noted with it, last checked 2026-07-30. Dose ranges, frequencies and storage times reflect what circulating protocols commonly state and are not established by these references.
- Frontiers in Pharmacology, 2022
First preclinical PK study of BPC-157. IV elimination half-life 15.2 min (rat) and 5.27 min (beagle); <30 min IM. Reports NO human pharmacokinetic data, which is why halfLifeHours is null rather than a number.
Run your own numbers
Pick BPC-157 from the preset list to start from a typical vial.
As printed on the vial label
How much you inject into the vial
1000 mcg = 1 mg
Fills in a common vial size and the low end of commonly cited protocols. Always check against your own vial.
on a 1 mL U-100 insulin syringe
- Concentration
- 5 mg/mL
- Volume
- 0.05 mL
- Doses in this vial
- 40
VialPal does the arithmetic — it does not tell you what to take. Dose decisions belong between you and a qualified clinician.